Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Federico

Showing results (181-190 of 233) with videos related to

Pageof 24
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2017
Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular LymphomaStefano Luminari, Angela Ferrari, Martina Manni, et al.
Blood Advances|February 9, 2021
ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell ProjectAndrei Shustov, Maria Elena Cabrera, Monica Civallero, et al.
Haematologica|May 31, 2022
High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baselineCédric Rossi, Marc André, Jehan Dupuis, et al.
European Journal of Haematology|March 11, 2015
Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL studyMassimo Gentile, Giovanna Cutrona, Stefano Molica, et al.
British Journal of Haematology|March 27, 2024
Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell ProjectMonica Civallero, Joseph G Schroers-Martin, Steven Horwitz, et al.
Hematological Oncology|September 9, 2022
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma projectCarlos Chiattone, Monica Civallero, Thais Fischer, et al.
Cancer|May 27, 2003
High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrenceCorrado Tarella, Alessandra Cuttica, Umberto Vitolo, et al.
Blood|February 24, 2006
Splenic marginal zone lymphoma: a prognostic model for clinical useLuca Arcaini, Mario Lazzarino, Nora Colombo, et al.
Blood|January 10, 2016
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma studySally F Barrington, Amy A Kirkwood, Antonella Franceschetto, et al.
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
T-cell lymphomas in South america and europeMonica Bellei, Carlos Sergio Chiattone, Stefano Luminari, et al.
Pageof 24

Showing results (181-190 of 233) with videos related to

Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2017
Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular LymphomaStefano Luminari, Angela Ferrari, Martina Manni, et al.
Blood Advances|February 9, 2021
ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell ProjectAndrei Shustov, Maria Elena Cabrera, Monica Civallero, et al.
Haematologica|May 31, 2022
High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baselineCédric Rossi, Marc André, Jehan Dupuis, et al.
European Journal of Haematology|March 11, 2015
Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL studyMassimo Gentile, Giovanna Cutrona, Stefano Molica, et al.
British Journal of Haematology|March 27, 2024
Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell ProjectMonica Civallero, Joseph G Schroers-Martin, Steven Horwitz, et al.
Hematological Oncology|September 9, 2022
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma projectCarlos Chiattone, Monica Civallero, Thais Fischer, et al.
Cancer|May 27, 2003
High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrenceCorrado Tarella, Alessandra Cuttica, Umberto Vitolo, et al.
Blood|February 24, 2006
Splenic marginal zone lymphoma: a prognostic model for clinical useLuca Arcaini, Mario Lazzarino, Nora Colombo, et al.
Blood|January 10, 2016
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma studySally F Barrington, Amy A Kirkwood, Antonella Franceschetto, et al.
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
T-cell lymphomas in South america and europeMonica Bellei, Carlos Sergio Chiattone, Stefano Luminari, et al.
Pageof 24